Market entry · Expert interview

Bringing a Korean filler into Vietnam's aesthetic clinics: registration, the clinic licence trap and who you sell through

Format
Modelled interview
As of
October 2026
Market
Vietnam
Industry
Aesthetic medicine
Length
≈ 30 min read
Ministry of HealthDrug Administration of VietnamKOTRAHugelCentral Dermatology Hospital
Modelled interview. Built from KIRA's interviews with aesthetic-injectable importers, distributors, dermatologists and plastic surgeons in Korea, with the lessons set in today's Vietnamese market. How the trade works comes from what those people told our analysts; every figure comes from a public source, marked next to the answer.

Summary

  • Korean fillers enter a market where the paperwork comes first: in the 11 months to mid-November 2025 the Ministry of Health granted 10,934 registration dossiers for Class C and D devices, and a Circular effective 22 November 2025 moved the issuing of new circulation numbers to a different department. 1 2
  • In Korea a foreign filler can be signed at a trade congress and launched fast because it is a device, not a drug; in Vietnam the maker still needs a registered product and a local partner who understands licensing. 3 4
  • Size estimates differ: one house puts medical aesthetics at USD 98.4 million in 2025, another puts hyaluronic-acid fillers alone at USD 120 million, with 2024 as the report's base year, so treat both as directional and build your own bottom-up count from clinics. 5 6
  • Clinics are where the risk sits: the Health Minister said in March 2025 that unlicensed facilities operate as salons and spas and that some staff inject filler after only basic vocational courses, so a distributor must check the buyer's licence before shipping. 7
  • The launch path that works in Korea has a counterpart in Hugel's Thailand launch: sponsoring a few prominent doctors first, with samples first for the few and later for the many 8; Hugel opened in Thailand with a seminar for local professionals and said it will keep working with key opinion leaders. 9
  • Doctors judge safety first, duration second and price third, and a cheaper filler that claims more than it delivers loses the doctors again. 10 11

Transcript

01The first thing a Korean maker gets wrong

KAKIRA Analyst

A Korean filler maker calls you and says it wants Vietnam. What do you tell it in the first ten minutes?

EXExpert

I tell it that in Vietnam the product does not start in the clinic, it starts in a file at the Ministry of Health. In the 11 months to mid-November 2025 the ministry granted 10,934 registration dossiers for Class C and D medical devices, and 381 import licences. 1 Registration is a real workload at the ministry, and a maker that has not started its file has not started its launch. 1

In Korea, my partners there tell me, a filler is approved as a device, so an importer can sign a foreign maker at a trade congress and be selling quite quickly. Toxins are drugs and slower. 3 Korean makers carry that feeling to Vietnam and are surprised. I do not tell them it is impossible. I tell them to hire the registration side before they hire the sales side. 4

KAKIRA Analyst

Who files, the maker or you?

EXExpert

I cannot give you a single answer, it depends on the structure the maker builds and what its registration adviser says. What I do know is that the Ministry of Health issued a Circular, number 44 of 2025, effective 22 November 2025, that moves the issuing of new circulation numbers for Class C and D devices to the Health Infrastructure and Medical Equipment Department and replaces the earlier Circular 19 of 2021. 2 I would not tell you your product's class, that is for your registration agent, but anyone who files today uses the new templates. 2

02Is the market worth the trouble

KAKIRA Analyst

How big is Vietnam for fillers, honestly?

EXExpert

Honestly, nobody knows, and I distrust anyone who says they do. One market-research house puts Vietnam's medical aesthetics at USD 98.4 million in 2025, growing 7.41% a year for 2026 to 2034. 5 Another puts hyaluronic-acid fillers alone at USD 120 million, with 2024 as its base year. 6 A part cannot be bigger than the whole, so those two are measuring different things or are rough. 5 6

What I trust is what I can count: clinics. Both houses point to Ho Chi Minh City and Hanoi, and one says they dominate because that is where the clinics are. 5 6 One of them cites a 20% yearly increase in the number of aesthetic clinics, but without a source, so I treat it as a mood, not a number. 6 My advice is to build your own count from clinic lists, then talk to ten of them. 6

KAKIRA Analyst

And the Korean angle, does Hallyu really help a Korean brand?

EXExpert

It helps with the story, not with the purchase order. The research says clinics are adopting Korean techniques, partnering with Korean device makers and recruiting Korean-trained surgeons, and I see that in how clinics decorate their waiting rooms. 5 But a doctor chooses a filler first on safety, then on how long it lasts, then on price. 10 Being Korean gets you a meeting, not a repeat order. 10

03Distributors, clinics and who sells to whom

KAKIRA Analyst

How is the channel built? Do you sell to every clinic yourself?

EXExpert

No. I am a small distributor and I cannot afford a national sales force. In Korea my importer colleagues told us the same: a large pharmaceutical importer with a national team sold toxin and filler together as a package to every aesthetic clinic, and the small ones admitted that the sales force is the real advantage and wished they could afford one. 12 In Vietnam it is the same shape on a smaller map. 12

A Korean sales manager told me KOTRA says the distribution structure here is complex and the licensing strict. 4 I agree on both. The complexity is partly that a distributor in Ho Chi Minh City does not automatically reach Hanoi, and partly that clinics buy from whoever they trust to deliver a genuine, documented box. 4

KAKIRA Analyst

So would you divide the country among several distributors?

EXExpert

That is the Korean pattern. Small importers there use designated distributors split by region or specialty, and sometimes they let them compete. 13 I would do something similar in Vietnam, one partner for the southern clinics and one for the north, but I would write the territories down. Competing distributors with the same box, one price list and no rules is how a brand ends up discounted in six clinics at once. 13

And do not ignore the doctors who are new to this. In Korea, general-practice doctors moved into injectables when their ordinary clinic income fell, and some plastic surgeons give injectables away to draw patients into surgery. 14 15 I see the same people in Vietnam. They are a real customer group, and also the group most likely to buy on price. 14

04Winning the first clinics

KAKIRA Analyst

How does a new filler actually get its first customers?

EXExpert

Through doctors, not through advertising. The standard path in Korea is to sponsor a few prominent society members to lecture and to give them a long period of free samples, and only later to give samples to the wider group of doctors. 8 Hugel did a version of this in Thailand: it held a launch seminar in Bangkok with a German plastic surgeon, a Thai professor and a local dermatologist, and over 250 local professionals attended. 9

In Vietnam I would copy the shape, not the budget. Pick two or three trusted dermatologists in Ho Chi Minh City and Hanoi, train beginners alongside them, and let them talk. The mistake I see is flooding everybody with samples in the first month, which tells doctors the brand is desperate. 8

KAKIRA Analyst

Is price a way in?

EXExpert

Only for some doctors. The opinion leaders will not switch on price alone, but the other dermatologists will. 16 And price-led entry has a trap. A low-price entrant in Korea took share from the pioneer, but doctors went back when its claims of longer duration did not hold up. 11 If your filler lasts as long as you say, price helps you. If it does not, price makes the failure faster. 11

On duration, doctors want enough time that patients are spared costly repeat visits, but not so much that a bad result lingers or the repeat revenue disappears. 17 So I would never let a maker print a duration claim that its own clinical file does not support. Semi-permanent products, in Korea, are kept for scars and noses rather than wrinkles because of the lasting risk. 18

05The clinic licence trap

KAKIRA Analyst

What are you most careful about when you take a new clinic as a customer?

EXExpert

Whether it is a real clinic. The Health Minister said in March 2025 that many unlicensed aesthetic facilities work illegally, disguised as beauty salons, spas or clinics, and that some workers perform filler and Botox injections after only basic vocational courses. 7 So before I ship a box I ask for the facility licence and the doctor's practising licence, and I keep a copy. 7

A small shop that gets a box of filler from me and gives it to a person with a basic course is my risk and my maker's risk. The Central Dermatology Hospital receives 1-3 beauty-related cases a day that need admission, the ministry said, and I do not want a case in that number with my batch number on the box. 7

KAKIRA Analyst

Do the rules on clinics change?

EXExpert

They may. The ministry said it is reviewing Decree 96/2023 and plans to propose amending it. 7 I cannot tell you what it will say, and nobody I know can. What I do is plan for stricter, not looser: a distributor who already checks licences will be fine, and a distributor who sells to anybody will not. 7

06The regulator's mood, and what trust costs

KAKIRA Analyst

You mentioned that mood matters. How do you mean?

EXExpert

In November 2025 a case against a beauty chain with 17 branches made the news. Police opened a smuggling case, the chain had distributed more than 8 million products, and the ministry revoked 80 declaration receipt numbers and 162 cosmetic products linked to it. 19 Those were cosmetics, not injectables, and I want to be careful. But after a case like that, the question every clinic asks me changes from price to paper. 19

So a documented chain from the maker to the box in the clinic is no longer a nice extra. A Korean maker told me KOTRA advises securing local certification early and building reliable after-sales networks, which is exactly what clinics now ask me for. 4 I would put the registration number, the batch and my invoice in one folder per clinic. 4

KAKIRA Analyst

Does a premium positioning help in that climate?

EXExpert

It can. In Korea clinics advertise their use of a premium toxin brand to patients as a signal of quality, and some Vietnamese clinics do the same with filler brands. 20 Toxin and filler also grow together, because they treat different depths and ages, so a maker with both is easier to place in a clinic than a maker with one. 21

07Advice to a newcomer, and what worries me

KAKIRA Analyst

A Korean maker is ready to go. What is your checklist?

EXExpert

First, start the registration file, and use the new templates. 2 Second, find a partner who can show licences and a delivery record, because licensing information is the thing sector people say is hardest to get. 4 Third, choose two opinion-leader doctors and train them first, before you give samples to anybody. 8 Fourth, write territories down. 13

And be realistic about the numbers. There are over 100 brands offering hyaluronic-acid fillers in Vietnam, so a clinic has many to choose from and a Korean flag is not enough. 6 Be honest about duration and about safety, because doctors judge in that order. 10

KAKIRA Analyst

What would change your mind about the market, and what worries you?

EXExpert

If the ministry made it clear and simple how to confirm that a filler is registered and the clinic is licensed, I would be more optimistic tomorrow. What worries me is the opposite: the minister herself says staff inject after basic courses, and a serious injury with a Korean filler would hurt every Korean brand at once. 7 In a market this size, with USD 98.4 million estimated for medical aesthetics, the early brands set the reputation of the whole country's products. 5

Sources and basis

  1. 1
    Vietnam's Ministry of Health, in the 11 months to mid-November 2025, granted 10,934 registration dossiers for Class C and D medical devices, 381 import licences and 1,445 Certificates of Free Sale
    Public source · Bao Dau thau (Public Procurement newspaper), 29 Nov 2025 · link
  2. 2
    Circular 44/2025/TT-BYT of the Ministry of Health, issued and effective 22 November 2025, delegates the issuing of new circulation numbers for Class C and Class D medical devices to the Health Infrastructure and Medical Equipment Department and sets the application templates; it replaces Circular 19/2021/TT-BYT
    Public source · Circular 44/2025/TT-BYT as published by LuatVietnam, accessed Oct 2026 · link
  3. 3
    In Korea, fillers are approved as medical devices, so an importer can sign a foreign maker at a trade congress and launch quickly; toxins are drugs and slower to approve
    KIRA field interviews · KIRA field interviews, Korean aesthetic injectable importers
  4. 4
    KOTRA report on Vietnam's aesthetic and medical device sector, reported in an article headlined on homecare devices: Vietnam has a population of nearly 100 million; entry barriers include a complex distribution structure and strict local licensing requirements; a sector representative told KOTRA Hanoi the greatest challenge is limited access to information on licensing rules and legal procedures; KOTRA advises securing local certification early and building reliable after-sales service networks
    Public source · KOTRA report reported by Vietnam News Agency (VOV), 4 Dec 2025 · link
  5. 5
    Vietnam medical aesthetics market: USD 98.4 million in 2025, forecast USD 190.8 million by 2034, growth of 7.41% a year for 2026-2034; Botox injections and dermal fillers have seen strong adoption in urban centres, especially Hanoi and Ho Chi Minh City; Korean popular culture is cited as a driver, and clinics are adopting Korean techniques, partnering with Korean device makers and recruiting Korean-trained surgeons (a market-research house's estimate, page last updated 8 June 2026)
    Public source · IMARC Group, Vietnam Medical Aesthetics Market, last updated June 2026 · link
  6. 6
    Vietnam hyaluronic-acid dermal filler market valued at USD 120 million (the page lists 2024 as its base year but does not explicitly date the figure); over 100 brands offer HA fillers in Vietnam; Ho Chi Minh City and Hanoi dominate because they have the most aesthetic clinics; the page cites, without a source, a 20% annual increase in the number of aesthetic clinics (a market-research house's estimate)
    Public source · Ken Research, Vietnam HA Dermal Fillers Market, published Jan 2026 · link
  7. 7
    As reported on 28 March 2025, the Health Minister said many unlicensed aesthetic facilities operate illegally, disguised as beauty salons, spas or clinics, and that some workers perform filler and Botox injections after only basic vocational courses; the ministry is reviewing Decree 96/2023 and plans to propose amending it; the Central Dermatology Hospital receives 1-3 beauty-related cases a day that need hospital admission
    Public source · VietNamNet Global, 28 Mar 2025 · link
  8. 8
    The standard launch path for injectables is to sponsor a few prominent society members to lecture and give them a long period of free samples, and only later to give samples to the wider group of doctors
    KIRA field interviews · KIRA field interviews, Korean aesthetic injectable importers
  9. 9
    Hugel launched its hyaluronic-acid filler in Thailand after Thai FDA approval in August 2023, and said it is the first Korean company to enter Thailand's filler, botulinum toxin and thread markets; the launch seminar in Bangkok was attended by over 250 local medical professionals, with a German plastic surgeon, a Thai university professor and a Thailand-based dermatologist speaking, and the company said it will keep working with key opinion leaders (the company's own statement)
    Public source · Asia Economy (Asiae), 29 Jan 2024 · link
  10. 10
    Doctors choose a filler first on safety, then on efficacy including how long it lasts, then on price
    KIRA field interviews · KIRA field interviews, Korean dermatologists and plastic surgeons
  11. 11
    A low-price entrant took share from the pioneer filler, but doctors switched back when its claims of longer duration did not hold up
    KIRA field interviews · KIRA field interviews, Korean aesthetic injectable importers
  12. 12
    In Korea a large pharmaceutical importer with a national sales team sold toxin and filler as a package to every aesthetic clinic; smaller importers admitted the national sales force is the real advantage and wished they could afford direct distribution
    KIRA field interviews · KIRA field interviews, Korean aesthetic injectable importers
  13. 13
    In Korea most importers are small and use designated distributors split by region or by specialty, sometimes made to compete with each other
    KIRA field interviews · KIRA field interviews, Korean aesthetic injectable importers
  14. 14
    Non-specialist doctors, such as gynaecologists and family doctors, move into injectables when their general clinic income falls
    KIRA field interviews · KIRA field interviews, Korean aesthetic injectable importers
  15. 15
    Plastic surgeons often give injectables free or discounted to draw patients into surgery
    KIRA field interviews · KIRA field interviews, Korean aesthetic injectable importers
  16. 16
    Opinion-leader doctors are not price-sensitive and will not switch on price alone; other dermatologists are price-sensitive
    KIRA field interviews · KIRA field interviews, Korean dermatologists and plastic surgeons
  17. 17
    Doctors want a duration long enough to spare patients costly repeat visits but not so long that a bad outcome lingers or repeat revenue disappears
    KIRA field interviews · KIRA field interviews, Korean dermatologists and plastic surgeons
  18. 18
    Semi-permanent fillers are kept for scars and nose correction rather than wrinkles because of the lasting risk of side effects
    KIRA field interviews · KIRA field interviews, Korean dermatologists and plastic surgeons
  19. 19
    Report of 28 November 2025: police opened a smuggling case against a beauty chain that had 17 branches and distributed more than 8 million products; the Ministry of Health revoked 80 declaration receipt numbers and 162 cosmetic products linked to it (cosmetics, not injectables)
    Public source · Viet Nam News, 28 Nov 2025 · link
  20. 20
    Clinics advertise the use of a premium toxin brand as a quality signal to patients
    KIRA field interviews · KIRA field interviews, Korean dermatologists and plastic surgeons
  21. 21
    Toxins and fillers grow together rather than compete, because they treat different wrinkle depths and age groups
    KIRA field interviews · KIRA field interviews, Korean aesthetic injectable importers

Key points

Practitioner views from KIRA Experts transcripts: modelled interviews built on KIRA's field interviews. How we work: Methodology.

More on Aesthetic injectables in Vietnam